SETD2 and obesity disorder: H3K36me3 mediated by SETD2 regulates the cell fate of mesenchymal stem cells (MSCs) in vitro and in vivo. Deficiency of SETD2 in BMSCs resulted in bone loss and bone marrow obesity.